Signal transducer CD24 also known as cluster of differentiation 24 or heat stable antigen CD24 (HSA) is a protein that in humans is encoded by the CD24gene.[1] CD24 is a cell adhesion molecule.
CD24 is a glycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. This gene encodes a sialoglycoprotein that is expressed on mature granulocytes and in many B cells. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. The protein also contributes to a wide range of downstream signaling networks and is crucial for neural development.[2] CD24 gene is found on chromosome 6 (6q21) An alignment of this gene's sequence finds genomic locations with similarity on chromosomes 1p36, 3p26, 15q21.3, 20q11.2 and Yq11.222. Whether transcription, and corresponding translation, occurs at each of these other genomic locations needs to be experimentally determined (source: NCBI).
References
↑Hough MR, Rosten PM, Sexton TL, Kay R, Humphries RK (July 1994). "Mapping of CD24 and homologous sequences to multiple chromosomal loci". Genomics. 22 (1): 154–61. doi:10.1006/geno.1994.1356. PMID7959762.
Li D, Zheng L, Jin L, et al. (2009). "CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection". Hepatology. 50 (3): 735–42. doi:10.1002/hep.23047. PMID19610054.
Piotrowski P, Lianeri M, Wudarski M, et al. (2010). "CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus". Tissue Antigens. 75 (6): HASH(0x2aadb3dd8b00). doi:10.1111/j.1399-0039.2010.01447.x. PMID20230526.
Nagy B, Szendroi A, Romics I (2009). "Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy". Pathol. Oncol. Res. 15 (2): 279–83. doi:10.1007/s12253-008-9077-1. PMID18752058.
Kim KH, Choi JS, Kim JM, et al. (2009). "Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium". Histol. Histopathol. 24 (3): 309–16. PMID19130400.
Sagiv E, Arber N (2008). "The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy". Expert review of gastroenterology & hepatology. 2 (1): 125–33. doi:10.1586/17474124.2.1.125. PMID19072375.
Bauerschmitz GJ, Ranki T, Kangasniemi L, et al. (2008). "Tissue-specific promoters active in CD44+CD24-/low breast cancer cells". Cancer Res. 68 (14): 5533–9. doi:10.1158/0008-5472.CAN-07-5288. PMID18632604.
Carl JW, Liu JQ, Joshi PS, et al. (2008). "Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway". J. Immunol. 181 (1): 320–8. doi:10.4049/jimmunol.181.1.320. PMID18566397.
Baumhoer D, Riener MO, Zlobec I, et al. (2009). "Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater". Mod. Pathol. 22 (2): 306–13. doi:10.1038/modpathol.2008.192. PMID19043399.
Wang W, Wang X, Peng L, et al. (2010). "CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation". Cancer Sci. 101 (1): 112–9. doi:10.1111/j.1349-7006.2009.01370.x. PMID19860845.
Sano A, Kato H, Sakurai S, et al. (2009). "CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma". Ann. Surg. Oncol. 16 (2): 506–14. doi:10.1245/s10434-008-0252-0. PMID19050962.
Yang XR, Xu Y, Yu B, et al. (2009). "CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery". Clin. Cancer Res. 15 (17): 5518–27. doi:10.1158/1078-0432.CCR-09-0151. PMID19706825.
Lee JH, Kim SH, Lee ES, Kim YS (2009). "CD24 overexpression in cancer development and progression: a meta-analysis". Oncol. Rep. 22 (5): 1149–56. doi:10.3892/or_00000548. PMID19787233.
Gekara NO, Weiss S (2004). "Lipid rafts clustering and signalling by listeriolysin O". Biochem. Soc. Trans. 32 (Pt 5): 712–4. doi:10.1042/BST0320712. PMID15493995.
Athanassiadou P, Grapsa D, Gonidi M, et al. (2009). "CD24 expression has a prognostic impact in breast carcinoma". Pathol. Res. Pract. 205 (8): 524–33. doi:10.1016/j.prp.2009.01.008. PMID19243896.
Ronaghi M, Vallian S, Etemadifar M (2009). "CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population". Psychiatry Res. 170 (2–3): 271–2. doi:10.1016/j.psychres.2009.01.002. PMID19896210.